Asset
MVT-1075
BioNTech SE American Depositary Share
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03118349 | phase1 | terminated | 2017-06-01 | 2018-04-11 | BioNTech Research & Development, Inc. | Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy |
FDA applications (0)
This company has no applications containing this asset.